5 Obesity Startups You Should Know (Allurion Technologies)
MDDI – Allurion has developed the Elipse Gastric Balloon, which is being billed as the first procedureless gastric balloon.
The Next Generation of Weight Loss
WEB MD – More than a third of Americans are obese, suggesting that diet and exercise alone aren’t enough for millions of people trying to slim down.
Data Presented on New Intragastric Balloons for Weight Loss
GENERAL SURGERY NEWS – One of the emerging approaches for weight loss in obese patients is the use of the intragastric balloon, and research on several forms of intragastric balloons was highlighted at the 2014 annual meeting of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).
A balloon for obesity: an option between medication and surgery?
LA TIMES – For many struggling with obesity, taking one of the newly approved prescription medications for weight loss (marketed as Qsymia, Belviq and Contrave) feels like climbing a mountain with a walking cane — it’s a little help, but not enough. And bariatric surgery — a permanent replumbing of the intestinal tract that is expensive and carries the risks of major surgery — feels like a bit too much help.
Expanding the Bounds of Weight Loss: Interview with Allurion Technologies Co-Founder, Shantanu Gaur
MEDGADGET – Over one-third of U.S. adults are obese, increasing their risk of certain conditions including heart disease, stroke, diabetes, and certain cancers. While bariatric procedures are indicated for refractory obesity with certain BMI criteria, those overweight individuals who do not quality are often at a loss for therapeutic solutions. The market for noninvasive innovations for these patients is emerging but is yet to have a consistently effective solution.